Reprinted with class tolerance from http://www.kaisernetwork.org. You can dream in light of the entire Kaiser Daily Health Policy Report, search the archives, or to up for email presentation at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Vigour Policy Report is published for kaisernetwork.org, a unfastened service of The Henry J. Kaiser Family Foundation© 2005 Monitory Timber Company and Kaiser Family Foundation. All rights reserved.

impotencia masculina

The US FDA cleared and CE marked embed represents a outstanding loan a beforehand in unicompartmental implant technology. The iUni is created using a virtual model of the knee made from the patient’s CT read over. The implants and all cutting and position guides are tax designed and matched to each patient’s unique anatomy. This signed correspond enables the implant to achieve precise anatomic alignment and natural knee kinematics with less surgical intervention than a traditional knee replacement. The accompanying expendable iJig™ instrumentation is also patient-specific and enables a simplified, reproducible surgical technique.

Dr. Franz Xaver Koeck, a leading orthopedic surgeon at Miserable Abbach, pass on carry out the yield along with Dr. Wolfgang Fitz, an orthopedic surgeon at Brigham and Women’s Clinic in Boston, Massachusetts. Dr. Fitz is also a co-designer of the iUni organized whole and a staff member at Harvard Medical School. The webcast will be moderated by Professor Dr. med. Dr. h. c. Joachim Grifka, Chief Surgeon and Clinical Director of the Orthopedic Clinic for the University of Regensburg at the Asclepius Clinic in Bad Abbach and President of the German Orthopedic Way of life 2008.

Viagra comprar

The ConforMIS proprietary iFit™ ‘image-to-implant’ technology converts CT and MR data into implants that are designed to harmonize with to the unique 3D design of a patient’s joint. The iFit originate modify interactively maps the diseased arena and the anatomy to which the impress wishes square with. Using the patient-specific bone geometry, the technology defines the shape and size of the femoral and tibial components as kind-heartedly as the paper instrumentation. The dogged-specific cutting and employment guides reduce the number of steps during surgery and provide precise leadership to accurately place the instruments, simplifying the surgical mode. This monogrammed passage eliminates many of the bone cuts required in traditional surgery, helping to reduce surgical and recovery times. More than 150 patient-particular partial knee resurfacing procedures enjoy been performed worldwide.

Viewers will have the possibility to email questions to the surgeons during the move on. This program is made admissible by an educational grant from ConforMIS, Inc.

ConforMIS, iUni, iJig and iFit are trademarks of ConforMIS, Inc.

Learn more about this bone preserving propositions to knee resurfacing by visiting: http://www.or-live.com

VNR: Knee Implant

OR-live.com

The scientists description in this week’s early online issue of the journal Proceedings of the National Academy of Sciences that the impact of dirty smoke from ships blazing high-sulfur nourish can be substantial, on some days accounting for nearly one-half of the fine, sulfur-rich particulate matter in the air known to be hazardous to human being health.

Their results have particular significance for the nation of California, which will lack, beginning next July, that all tankers, cargo and cruise ships sailing into a California port switch to more expensive, cleaner-burning fuels when they disappoint a amount to within 24 miles of the coast. Like foreign rules requiring clean-burning ship fuels are set to take effect in 2015.

While those regulations are intended to reduce the potential hazards sully despatch smoke may put portray to human health and the environment-which some researchers have estimated may be top for as many as 60,000 deaths worldwide and a expenditure to the U.S. economy of $500 million a year-no equal knows the authentic impact of dispatch smoke. The grounds is that air quality experts have been unable to quantify the specific contribution of ship smoke to the air blighting of coastal cities-until straight away occasionally.

“This is the outset study that shows the contribution of ships to fine particulates in the spirit,” said Mark Thiemens, Dean of the Allotment of Physical Sciences and a professor of chemistry and biochemistry at UCSD who headed the research team. “Ships are genuinely unregulated when it comes to ventilate fouling standards. What we wanted to find into the open air was the contribution of ships to the air polluting in San Diego. And what we inaugurate was a surprise, because no one expected that the contribution from ships of steady sulfur-rich particles called brief sulfate would be so high.”

Primary sulfate, or SO4, is produced when ships burn a cheap, sulfur-rich fuel called “bunker grease.” Most of the sulfur emitted by ships parching bunker oil is released as sulfur dioxide, or SO2, a gaseous pollutant which is eventually converted to sulfate in the air. But although SO4 may be a smaller component in ship emissons, the scientists say, these primary sulfate particulates are particularly harmful to humans, because they are conspicuously fine microscopic particles, less than 1.5 microns or millionth of a meter in appraise. As a culminate, they can travel extremely elongated distances because they stay in the atmosphere for longer periods and, unlike bigger dust grains and particles that are removed by the assemblage when breathed, remain in the lungs.

“The consequence of primary sulfate is most often ignored in assessments of the modify of ship emissions on ventilate excellence because less than 7 percent of all sulfur emitted by ships is create in primary sulfate particles,” said Gerardo Dominguez, a postdoctoral researcher at UCSD and the first novelist of the holograph. “But our results suggest that this component of ship emissions is conspicuous and should not be ignored in the future. Shrewd how much sulfate from ships is in the air will also appropriate us to well-advised understand what happens to the other 93 percent of sulfur emitted by ships.”

Working with Thiemens, Dominguez developed a chemical fingerprinting technique that allowed the scientists to distinguish ranking sulfate from vessel smoke from the tailpipe emissions of trucks, cars and other sources. This was done using an oxygen-isotope procedure developed by Thiemens that allows scientists to determine the signature of sulfate molecules made in the aerosphere. The researchers discovered that primary sulfates from ship engines incorporated molecular oxygen (the order we breathe in to live) and are obviously distinguished from worthy sulfates from car and trade diesel emissions.

Sampling express at the ruin of the pier at the UC San Diego’s Scripps Institution of Oceanography in La Jolla, the scientists found that the smoke from ships contributed as much as 44 percent of the sulfate rest in fine particulate dilemma in the heavens of coastal California. On the days when the adjust of ship sulfate approached one-half of the fine particulate matter, the scientists determined from ascendancy supervision and speed calculations that ships burning lofty sulfur fuel in the Los Angeles, Long Bank and San Diego ports were a major leverage.

“We organize that in San Diego, the Port of Los Angeles can be a informative favouritism on make public quality because these satisfactory particulates can travel so succeed,” said Dominguez.

impotencia masculina

The researchers said the chemical fingerprinting techniques they developed in their scan concerning ship primary sulfur emissions should benefit the California Air Resources Board as all right as regulators in other states and countries proctor the impacts of ships afar their coasts as new restrictions on bunker lubricant ablaze by ships are implemented.

“This longing tell us whether California’s new regulation requiring cleaner excited fuel 24 miles off the coast is having the effect it’s intended to entertain,” said Thiemens. “And because a large part of the world’s citizens live in major cities with shipping ports-such as Different York Urban district, San Francisco, Hong Kong, Houston, and Singapore-and broad shipping is expected to increase in the decades to sign in, this should usurp design makers around the unbelievable make more informed decisions take improving the health of their citizens.”

Other UCSD researchers involved in the investigate were chemist Terri Jackson, graduate student Lauren Brothers and undergraduate students Burton Barnett and Bryan Nguyen. The research hurl was financed by grants from the California Air Resources Committee, the Camille and Henry Dreyfus Endowment, and the UC Backup of the President.

UCSD News

Their work will be published in the April 1st issue of Genes & Development.

With each round of cell division, telomeres are progressively shortened. In fact, when telomeres reach a “critical length” the cell can no longer multiply. This has lead many scientists to conclude that the erosion of telomeres is a key feature of the aging process, while the aberrant addition to telomere ends (and increased proliferative capacity that this endows) is an integral part of cancer progression.

The mechanisms by which a cell regulates activity at its telomeres (be it positive or negative), is an actively investigated area, with direct implications for understanding aging and cancer.

Telomeres are elongated by an enzyme called Telomerase (hTERT). Telomerase is generally only active in fetal, germ, and cancer cells; it is normally repressed in most somatic (body) cells. This new work by Dr. Chung and colleagues shows how cells keep telomerase activity in check, by identifying a novel protein that tags its key partner for degradation.

Hsp90 is an abundant cellular protein that specifically interacts with hTERT to promote telomere formation. The Hsp90 protein is increased in several tumors and may increase the addition of telomere repeats several-fold. Chung’s group has now identified a second protein, called MKRN1 that acts on hTERT to promote its degradation. MKRN1 belongs to a class of proteins called ubiquitin ligases that catalyze the addition of a small protein, called ubiquitin, to mark hTERT for destruction by cellular degradation machinery.

Increasing the amount of MKRN1 in cells promotes the degradation of hTERT and leads to a decreased telomerase activity. This degradation is even more pronounced in cells that are treated with the drug geldanamycin, which is a specific antagonist of Hsp90. Consequently, this causes the shortening of telomere lengths. Using biochemical assays, it was demonstrated that MKRN1 directly interacts with hTERT to promote the addition of the ubiquitin moieties.

Impotencia sexual masculina

These results indicate that two opposing forces in human cells influence basal levels of active hTERT. The first is an interaction with Hsp90 that promotes this activity and the other is protein degradation, mediated by MKRN1 and the balance of these two maintains cellular telomerase levels. The identification of MKRN1 as a negative regulator of telomere lengths is an important finding in elucidating how cells may achieve immortality to lead to cancers.

Further studies will be important to shed light on how MKRN1 may be used as a therapeutic target for checking the uncontrolled division of tumor cells. Dr. Chung is confident that “MKRN1 plays an important role in modulating telomere homeostasis through dynamic control of hTERT protein stability and could represent a novel target for anti-cancer drug development.”

http://www.cshl.org/

“Reprinted with permission from http://www.kaisernetwork.org. You can view the undivided Kaiser Regular Health Means Scrutinize, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Always Robustness Policy Report is published recompense kaisernetwork.org, a emancipate service of The Henry J. Kaiser Family Foundation . © 2005 Admonition Board Company and Kaiser Family Foundation. All rights unemotional.

impotencia sexual masculina

January-September 2005 – - 1,299
January-September 2005 – - 1,386
January-September 2005 – - 4,137

In 2003, the worst year, West Nile Virus had only just arrived at the outskirts of the West Littoral states. 2003 aphorism most cases arise in Nebraska, South Dakota and Colorado.

Colorado has seen a immense stop, from around 3,000 in 2004 to well-grounded 48 in 2005. California has had 593 reported humanitarian cases so high this year. Even although many more carriers (birds and mosquitoes) keep been spotted in the stage this year.

cialis

West Nile Virus infects humans via mosquitoes that pull someone’s leg bitten infected birds.

Scientists cannot explain why the number of human cases has dropped while the number of carriers has gone up. Perhaps people are taking more precautions (insect repellent).

Even-tempered humid, warm areas with lots of marshes and areas of standing water, such as Alabama, Mississippi and Florida have fewer reported cases.

In order for the mosquito to grow it needs stagnant (standing) water. If you can demonstrate sure your buckets are empty, assured pure all puddles and look distant throughout any areas of stagnant distilled water you resolution be denying the mosquito the come about to reproduce.

Written by Christian Nordqvist
Rewriter – Medical News Today

Copyright: Medical Good copy Today

Not to be reproduced without approval of Medical News Today

The program is join in of a ungentlemanly, $250 million native effort to at once credit the latest techniques in regenerative medicine to the treatment of wounded soldiers. DOD officials unveiled the Armed Forces Begin instead of Regenerative Medicine (AFIRM). AFIRM is made up of two civilian examine consortiums working with the U.S. Army Institute into Surgical Research at Fort Sam Houston in San Antonio.

“This is by deteriorated the largest federal investment everlastingly made in regenerative pharmaceutical, and it’s no matching that the Texas Medical Center is playing an important role,” said Rice University President David Leebron. “Rice and UT-Houston’s collaborative research in this area is at the forefront of this straight away growing follower.”

One of AFIRM’s civilian consortiums is led by the Wake Forest Institute for Regenerative Medicine and the McGowan Society for Regenerative Medicine at the University of Pittsburgh. The other is led by Rutgers University and the Cleveland Clinic.

Rice bioengineer Antonios Mikos and UT-Houston surgeon Mark Wong are overseeing the Wake Forest consortium’s research on craniofacial reconstruction. Mikos is Rice’s J.W. Cox Professor in Bioengineering, professor of chemical and biomolecular engineering and the director of Rice’s Center after Excellence in Series Engineering. Wong is associate professor and chairman of the Department of Viva voce and Maxillofacial Surgery at the University of Texas Dental Branch at Houston. Rice and UT-Houston force receive $2 million over the next five years to forefront the development of advanced tissue engineering technologies, novel reconstructive surgical techniques and innovative painkiller therapies that can help wounded soldiers.

“Dr. Mikos and Dr. Wong have been pioneers in the development of young tissue-engineering technologies that can be used for facial reconstruction throughout victims of catastrophic mischief,” said Dr. Peter Davies, governmental vice president for check in at UT-Houston.

Tissue engineering is a solid-growing biomedical discipline that aims to quickly grow human tissues counterpart bone, cartilage and skin that can be surgically transplanted without risk of also brush. Web engineers often use a patient’s own cells as the basis for new chain, placing them on biodegradable templates and stimulating them with chemical and physical cues.

“All of our efforts, both here in Houston and around the nation, are aimed at moving forward right now to enfranchise therapies to the thousands of soldiers who have been wounded in this unceasingly a once of war,” Mikos said.

Mikos, a founding editor of the dossier Tissue Engineering and president-elect of the North American Web Engineering and Regenerative Medicine Worldwide Society, is one of the world’s chief experts on tissue engineering and regenerative medicament.

Technology investigated by the consortium partners in craniofacial reconstruction on include the use of biopolymers as matrices in the direction of tissue regeneration and the confinement of different drugs to abort infection and stimulate bind healing. Additional fabric-engineering projects that take up of age stem cells to reconstruct lost appendages such as ears and noses resolution also be investigated.

“We are honored to be let go of this consortium, which choice allow us to be the source to realization assorted years of collaborative research with Rice University and apply novel techniques to aid the reconstruction of devastating facial defects continuous by our military personnel,” Wong said.

Traditionally, it can take years for laboratory breakthroughs to be translated into clinical practice. Mikos said it is invigorating for engineers and doctors to work together closely — at every stage of research — if cutting-head start technology is to be fast transitioned to patients.

Wong, the director of the UT Dental Division at Houston’s Verbal and Maxillofacial Surgery residency training program, holds surgical appointments at Plaque Hermann Hospital-Texas Medical Center, Lyndon B. Johnson Generalized Sanatorium, Ben Taub Ill-defined Hospital and The Methodist Health centre. He said AFIRM’s bench-to-bedside research efforts in Houston see fit helpers ensure that the technology developed for the military command also benefit civilian victims of trauma.

Davies said, “This is the sort of groundbreaking translational research that is being conducted in UT-Houston’s fashionable research facility, the Center for Clinical and Translational Sciences, a state-of-the-talent clinical research ability funded by everybody of the first (Clinical and Translational Science Awards) made by the National Institutes of Health.”

The long-unbroken partnership between Mikos and Wong is the purpose for the research. This partnership has been rewarded with several grants from the Patriotic Institutes of Form, the Oral and Maxillofacial Surgery Organizing and labour. It has also provided the basis for a seam educational program combining oral and maxillofacial surgery residency training at UT-Houston with a doctorate in bioengineering at Rice.

Viagra generico en españa

Thanks to an existing relationship between the military and the UT Dental Branch’s oral and maxillofacial surgery residency program, the military’s own trauma surgeons will get firsthand experience with all the revitalized facial reconstruction techniques developed and tested by AFIRM. Under the residency program, surgeons from both the Army and Air Wrench spend occasion in Houston gaining savoir faire in trauma stewardship.

“We are fortunate to have a thorough relationship with UT-Houston where we can come in experience with wider variety real-existence trauma situations, similar to those we would manage in Iraq and Afghanistan,” said Capt. Curt Hayes, chief regional of word-of-mouth and maxillofacial surgery at Lackland Freshen Compel Base’s Willford Hall Medical Center in San Antonio. “This new let presents the chance quest of improving battlefield management and outcome for hard-tissue injuries that are sustained by our military members.”

Each of AFIRM’s civilian consortiums was awarded $42.5 million during a period of five years. In addition, the two consortia are bringing local unconcealed and private matching funds amounting to more than $180 million that choose be added to their research budgets — for a entire of more than $250 million available concerning research.

Rice and UT-Houston are two of the 46 member institutions in the Texas Medical Center (TMC), one of the world’s largest medical complexes. TMC institutions acquit more than $1 billion worth of check in and see more than 5 million patients each year.

“Rice and UT-Houston’s AFIRM research program calls for doctors and bioengineers to work side-by-side to rapidly translate new discoveries from the laboratory to the operating accommodation,” said Rice Provost Eugene Levy. “This is an outstanding benchmark of the kind of joint, tightly interwoven research that at one’s desire be greatly facilitated and that Rice plans to conduct with UT-Houston and its other TMC partners in the new Collaborative Check out Center slated to get under way in mid-2009.”

UT-Houston President Dr. James Willerson said, “This is a most pithy endeavor and is a acknowledgement to the strength we can carry out under the aegis collaboration in the Texas Medical Center.”

—————————-
Article adapted by Medical News Today from original press deliver.
—————————-

Source: David Ruth

Rice University

It is well established that changing people’s substance of answerability can change their behavior. But what would happen if people came to confidence in that their behavior was the inevitable offshoot of a causal chain beyond their control – a predetermined fate beyond the reach of free will?

Surprisingly, the link between fatalistic beliefs and unethical behavior has not in any way been examined scientifically – until now. In two latest experiments, psychologists Kathleen Vohs of the University of Minnesota and Jonathan Schooler of the University of British Columbia unambiguous to inquire this knotty calm circulate in the lab, and they figured out an innovative conduct to do it. Vohs and Schooler set out to see if if not plain-spoken people would cheat and tall tale if their beliefs in liberate will were manipulated.

The psychologists gave college students a mathematics exam. The math problems appeared on a computer colander, and the subjects were told that a computer glitch would cause the answers to appear on the screen as well. To block the answers from showing up, the students had to hit the space bar as in time as the problems appeared.

Comprar viagra espana

In fact, the scientists were observing to see if the participants surreptitiously acquainted with the answers instead of solving the problems honestly on their own. Prior to the math assay, Vohs and Schooler hardened a prosperously-established method to prime the subjects’ beliefs regarding free drive: some of the students were taught that science disproves the thought of unsparing will and that the misapprehension of informal hand down was a mere artifact of the brain’s biochemistry whereas others got no such indoctrination.

The results were clear: those with weaker convictions involving their power to manage their own destiny were more apt to cheat when given the moment as compared to those whose beliefs about controlling their own lives were liberal untouched.

Vohs and Schooler then went a step further to see if they could tune in to people to cheat with unmistakable end and effort. In a second study, the experimenters set up a disparate deception: they had the subjects book a very difficult cognitive test. Then, the subjects solved a series of problems without supervision and scored themselves. They also “rewarded” themselves $1 for each correct answer; in order to collect, they had to walk across the room and help themselves to money in a manila envelope.

The psychologists had formerly primed the participants to have their beliefs in free of charge will bolstered or reduced by having them read statements supporting a deterministic stance of human behavior. And the results were equitable as robust. As reported in the January issue of Psychogenic Science, a journal of the Association as a service to Intellectual Expertise, this study shows that those with a stronger belief in their own democratic will were less apt to filch money than were those with a weakened belief.

Although the results of this study point to a signal value in believing that free transfer exists, it clearly raises some impressive societal questions about exclusive beliefs and personal behavior.

—————————-
Article adapted by Medical News Today from starting press unfetter.
—————————-

Author Contact: Kathleen Vohs

Psychological Subject is ranked extent the lop 10 general bats journals in place of impact by the Institute for Scientific Information. The article is entitled “The Value of Believing in Free Will: Encouraging a Creed in Determinism Increases Cheating.”

Source: Rebecca Monro

Association over the extent of Psychogenic Subject

“We are encouraged by prelude figures, which have shown TMC278 to be active against HIV in patients who have not in days of yore received treatment,” said Roger Pomerantz, MD, President of Tibotec Research and Development. “These phase III studies choice forearm additional information on the aegis and efficacy of this likely modern treatment option.”

The first phase III, double-impervious, randomized study, known as TMC278-C209 or ECHO (Efficacy Weighing in treatment-naïve HIV-infected subjects Of TMC278 and EFV), evaluates TMC278 (25 mg) once daily oral pastille versus EFV (600 mg) sporadically daily, when combined with a regular unseen regimen consisting of emtricitabine + tenofovir disoproxil fumarate. A second phase III, bent over-blind, randomized swot, known as TMC278-C215 or THRIVE (TMC278 against HIV, in a once daily RegImen Versus Efavirenz), evaluates TMC278 (25 mg) once continuously versus EFV (600 mg) in the same instant every day, when combined with an investigator-selected background regimen consisting of two N[t]RTIs (abacavir + lamivudine or tenofovir disoproxil fumarate + emtricitabine or zidovudine + lamivudine).

Impotencia sexual masculina

Each scan is being conducted at more than 100 sites in over 20 countries, including Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Portugal, Romania, Russia, Spain, Sweden and the UK, and others in Africa, Asia, Latin America and North America. The trials each endeavour to enroll approximately 680 patients. To be unwed, patients must have a viral load higher than 5,000 HIV-1 RNA copies/mL at screening and obligated to never have planned infatuated anti-HIV drugs late to enrolling, as well as endure other eligibility criteria. The primary endpoint of the studies is to assess the proportion of patients with a confirmed plasma viral load < 50 HIV-1 RNA copies/mL at week 48 on TMC278 vs. control (EFV). The studies will last object of a maximum duration of 106 weeks, which includes a maximum of a six-week screening years, a 96-week treatment spell and a four-week succeed-up era.

Results from both of these studies will be submitted to the European Medicines Agency (EMEA) as part of the Marketing Authorisation Application during TMC278.

Thoroughly the application of its thorough understanding of virology and viral rebelliousness, Tibotec has become an established leader in HIV/AIDS, having developed and made available two antiretroviral agents appropriate for the treatment of HIV. TMC278 is the third anti-HIV intricate to be developed by Tibotec Pharmaceuticals, which is also developing other investigational compounds for the treatment of hepatitis C and tuberculosis.

For additional facts on inclusion and disallowance criteria in the interest of both of these studies, please see www.clinicaltrials.gov.

About Tibotec Pharmaceuticals

Tibotec Pharmaceuticals, based in Cork, Ireland, is a pharmaceutical dig into and development friends. The Company’s main research and circumstance facilities are in Mechelen, Belgium with offices in Yardley, PA, USA. Tibotec is dedicated to the unearthing and occurrence of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical destitution. http://www.tibotec.com/

Tibotec is a member of the Johnson & Johnson menage of companies.

Leading Looking Communication

This clip disseminate contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on course expectations of future events. If underlying assumptions make good fallacious or unknown risks or uncertainties happen, actual results could vary palpably from Tibotec’s expectations and projections. Risks and uncertainties count blanket persistence conditions and competition; economic conditions, such as biased rate and currency return reckon fluctuations; technological advances and patents attained by competitors; challenges inherent in new by-product phenomenon, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward healthfulness care cost containment. A further list and record of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Copies of this Coin 10-K, as entirely as future filings, are to hand online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Tibotec does not undertake to update any send on-looking statements as a result of experimental information or future events or developments.

Daniel J Edelman Ltd a company registered in England with suite number 924113 and its registered charge at Southside, 105 Victoria Street, London SW1E 6QT, United Kingdom

Tibotec Pharmaceuticals

Clinical investigators from pre-eminent oncology and hematology scrutinize centers intent furnish information through several articulated and circular presentations reporting noted findings in leukemia-related disorders, such as prognostic indicators for chronic lymphocytic leukemia (CLL) and side effects such as chemotherapy-induced neutropenia.

Campath is indicated in the In agreement States as a single agent for the treatment of B-stall chronic lymphocytic leukemia (B-CLL). Leukine is indicated notwithstanding use following induction chemotherapy in patients 55 years and older with acute myelogenous leukemia (AML) to lop off the time to neutrophil recovery and to reduce the incidence of obdurate and lifeblood-menacing infections and infections resulting in death.

“We are pleased to see continued developments on both Campath and Leukine,” said Pam Cyrus, Vice President, Medical Affairs, Oncology, Bayer HealthCare Pharmaceuticals. “These studies further demonstrate Bayer’s continuing commitment to supporting enquire to benefit the lives of people living with cancer.”

Abstracts are sometimes at one’s disposal on the ASH Web site at http://www.hematology.org.

Expanse the data that will be presented are the following:

Campath:

– Poster 3164 (December 8, 5:30 p.m. PST) — Clinical Outcome of B-Cell Chronic Lymphocytic Leukemia Following Alemtuzumab Psychotherapy: Retrospective Investigate Within Various Cytogenetic Risk Categories

– Poster 329 (December 8, 12:00 p.m. PST) — Subcutaneous Alemtuzumab (Campath) in Fludarabine-Refractory CLL: Fixed Results of the CLL2H Lawsuit of the GCLLSG and Comprehensive Analysis of Prognostic Markers

Leukine:

– Uttered Presentation 665 (December 8, 3:30 p.m. PST) — Balancing of Infection-Related Hospitalization Risk and Associated Costs Total Patients Receiving Sargramostim (Leukine), Filgrastim (Neupogen), and Pegfilgrastim (Neulasta) as a remedy for Chemotherapy-Induced Neutropenia

– Poster 3173 (December 8, 5:30 p.m. PST) — Common sense with Fludarabine, Cyclophosphamide, Rituximab (FCR) Extra GM-CSF in Frontline Therapy for Chronic Lymphocytic Leukemia (CLL)

About Campath

Campath was the first monoclonal antibody approved by the United States Food and Drug Regulation (FDA) for the treatment of B-cell dyed in the wool lymphocytic leukemia (B-CLL). In September 2007, the FDA approved a supplemental Biologics Validate Application (sBLA) payment Campath and granted regular approval inasmuch as separate-agent Campath for the treatment of B-CLL. Campath was initially approved in 2001 under accelerated approval regulations for the treatment of B-CLL in patients who have been treated with alkylating agents and who clothed failed fludarabine remedy. Campath was developed by Genzyme Corporation. Campath is marketed in the U.S. by Bayer HealthCare Pharmaceuticals Inc., as Campath, and outside the United States as MabCampath(R).

Prominent Safety Knowledge

ADVICE: CYTOPENIAS, INFUSION REACTIONS, AND INFECTIONS

– Cytopenias: Serious, including unavoidable, pancytopenia/marrow hypoplasia, autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia can chance in patients receiving Campath. Single doses of Campath greater than 30mg or cumulative doses greater than 90mg per week development the incidence of pancytopenia.

– Infusion Reactions: Campath administration can come to pass in acute, including inevitable, infusion reactions. Carefully monitor patients during infusions and restrain Campath in requital for Grade 3 or 4 infusion reactions. Grade escalate Campath to the recommended amount at the instatement of therapy and after disruption of therapy since 7 or more days.

– Infections: Serious, including ruinous, bacterial, viral, fungal, and protozoan infections can occur in patients receiving Campath. Administer prophylaxis against Pneumocystis jiroveci pneumonia (PCP) and herpes virus infections.

Campath is indicated as a solitary select agent in the interest the treatment of B-chamber chronic lymphocytic leukemia (B-CLL). Campath is administered as an IV infusion through two hours and should be dose escalated to recommended dose of 30 mg/day three times per week for 12 weeks. Patients are premedicated with oral antihistamine and acetaminophen prior to dosing. The most commonly reported adverse reactions are infusion reactions (fever, chills, hypotension, urticaria, nausea, rash, tachycardia, dyspnea), cytopenias (neutropenia, lymphopenia, thrombocytopenia, anemia), and infections (CMV viremia, CMV infection, other infections). In clinical trials, the frequency of infusion reactions was highest in the commencement week of treatment. Other commonly reported adverse reactions encompass vomiting, abdominal anguish, insomnia and anxiety. The most commonly reported urgent adverse reactions are cytopenias, infusion reactions, and immunosuppression/infections. See “Warnings and Precautions,” and “Adverse Reactions” sections of roundish Prescribing Information.

Round Leukine

Leukine is a growth factor that helps spat infection and infirmity in set aside patients by enhancing inoculated cell function. Leukine was approved in the Of one mind States in 1991 and is marketed by Bayer HealthCare Pharmaceuticals. Leukine is the lone proliferation factor approved in the U.S. for use following induction chemotherapy in older adults with piercing myelogenous leukemia (AML) to prune the time to neutrophil rescue and reduce the number of monastic and life-threatening infections and infections resulting in death. Leukine also has been approved in the U.S. for use in four additional indications: myeloid reconstitution following allogeneic and autologous bone marrow transplantation (BMT), outside blood stem cubicle (PBSC) mobilization and subsequent myeloid reconstitution in patients undergoing PBSC transplantation, and bone marrow transplantation failure or engraftment delay. Leukine is available in two formulations, both of which are suitable for IV infusion and subcutaneous injection:

– Liquid: 500 mcg/mL infertile explication in multi-use vial

– Lyophilized powder: 250 mcg in individual-use vial ready seeking unproductive reconstitution

Leukine has been worn to treat nearly 250,000 cancer patients in the U.S. since 1991. Among its indications, Leukine is the only myeloid wart factor approved to depreciate the number of infections resulting in early death following induction chemotherapy in older adults with AML.

Near Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals deal of Bayer HealthCare, an affiliate of Bayer AG. One of the world’s leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the universal activities of the Animal Health, Consumer Custody, Diabetes Care, and Pharmaceuticals divisions. In the Of one mind States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women’s Healthcare, Diagnostic Imaging, General Medicine, Hematology/Neurology, and Oncology. The company’s aim is to chance and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Fro Genzyme

Whole of the world’s leading biotechnology companies, Genzyme is dedicated to making a primary positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and reported revenues in 2007 of $3.8 billion. In 2007, Genzyme was chosen to experience the Public Medal of Technology, the highest honor awarded by the President of the United States someone is concerned technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme is a chairwoman in the effort to exhibit and apply the most advanced technologies in the life sciences. The company’s products and services are focused on rare inherited disorders, kidney bug, orthopaedics, cancer, uproot, and diagnostic testing. Genzyme’s commitment to modernization continues today with a substantial increase program focused on these fields, as well as unaffected disease, contagious disease, and other areas of unmet medical sine qua non.

Genzyme(R), Campath(R) and MabCampath(R) are registered trademarks of Genzyme Corporation. All rights reserved.

Forward-looking Statements

This news unloosing contains forward-looking statements based on up to date assumptions and forecasts made by Bayer Group management. Diversified known and unknown risks, uncertainties and other factors could lead to constituents differences between the authentic tomorrow’s results, financial state of affairs, development or act of the company and the estimates given here. These factors list those discussed in our annual and interim reports to the Frankfurt Stock Dealing and in our reports filed with the U.S. Securities and Reciprocity Commission (including our Form 20-F). The retinue assumes no liability whatsoever to update these forward-looking statements or to conform them to following events or developments.

Viagra

Bayer HealthCare Pharmaceuticals Inc.

http://www.pharma.bayer.com

View cure-all information on Campath; Leukine.